Chugai Pharma | 4519 - Sales Revenues

Stock Price
7,940.00
Daily Change
495.00 6.65%
Monthly
-8.31%
Yearly
-3.39%
Q2 Forecast
8,500.93

Chugai Pharma reported JPY321.75B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Astellas Pharma JPY 537.93B 33.28B Mar/2026
Chugai Pharma JPY 321.75B 24.55B Mar/2026
Daiichi Sankyo JPY 558.11B 57.35B Dec/2025
Eisai JPY 219.94B 22.58B Dec/2025
Kyowa Hakko Kirin JPY 147.38B 28.58B Dec/2025
M3 JPY 93.51B 8.82B Dec/2025
Otsuka Holdings JPY 630.34B 19.81B Mar/2026
Shionogi JPY 147.72B 34.52B Dec/2025
Sumitomo Dainippon JPY 120.62B 1.5B Dec/2025
Takeda JPY 1.19T 80B Dec/2025
Terumo JPY 296.63B 21.66B Dec/2025